Capital Bank & Trust’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-119,922	Closed	-$11.7M	–	128
2021 Q2	$11.7M	Sell	119,922 -1,078	-0.9%	-$103K	0.14%	124
2021 Q1	$11.8M	Sell	121,000 -108,880	-47%	-$11.4M	0.14%	124
2020 Q4	$22M	Sell	229,880 -2,354	-1%	-$227K	0.27%	93
2020 Q3	$22.3M	Sell	232,234 -46,128	-17%	-$5.34M	0.3%	84
2020 Q2	$34M	Buy	278,362 +1,615	+0.6%	+$178K	0.5%	59
2020 Q1	$24M	Sell	276,747 -12,418	-4%	-$1.22M	0.4%	69
2019 Q4	$31.1M	Sell	289,165 -2,617	-0.9%	-$274K	0.4%	72
2019 Q3	$26.3M	Sell	291,782 -31,032	-10%	-$2.9M	0.36%	72
2019 Q2	$27.2M	Buy	322,814 +106,796	+49%	+$8.77M	0.34%	80
2019 Q1	$19M	Buy	216,018 +168,394	+354%	+$14.1M	0.24%	93
2018 Q4	$3.4M	Buy	47,624 +47,554	+67,934%	+$4.56M	0.05%	150
2018 Q3	$9K	Hold	70	–	–	﹤0.01%	672
2018 Q2	$7K	Buy	+70	New	+$6.27K	﹤0.01%	564